Back to GetFilings.com



Table of Contents

 


 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2003

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File No. 0-20292

 

AMPEX CORPORATION

(Exact name of Registrant as specified in its charter)

 

Delaware

 

13-3667696

(State of Incorporation)

 

(I.R.S. Employer Identification Number)

 

1228 Douglas Avenue

Redwood City, California 94063-3199

(Address of principal executive offices, including zip code)

 

(650) 367-2011

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

As of March 31, 2003, the aggregate number of outstanding shares of our Class A Common Stock, $.01 par value, was 63,841,796. There were no outstanding shares of our Class C Common Stock, $0.01 par value.

 



Table of Contents

 

AMPEX CORPORATION

FORM 10-Q

 

Quarter Ended March 31, 2003

 

INDEX

 

         

Page


PART I—FINANCIAL INFORMATION

Item 1.

  

Financial Statements

  

3

    

Consolidated Balance Sheets (unaudited) at March 31, 2003 and December 31, 2002

  

3

    

Consolidated Statements of Operations (unaudited) for the three months ended March 31, 2003 and 2002

  

4

    

Consolidated Statements of Cash Flows (unaudited) for the three months ended March 31, 2003 and 2002

  

5

    

Notes to Unaudited Consolidated Financial Statements

  

6

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

14

Item 3.

  

Quantitative and Qualitative Disclosure about Market Risk

  

29

Item 4.

  

Controls and Procedures

  

29

PART II—OTHER INFORMATION

    

Item 1.

  

Legal Proceedings

  

29

Item 2.

  

Changes in Securities and Use of Proceeds

  

31

Item 3.

  

Defaults Upon Senior Securities

  

31

Item 4.

  

Submission of Matters to a Vote of Security Holders

  

31

Item 5.

  

Other Information

  

31

Item 6(a).

  

Exhibits

  

31

Item 6(b).

  

Reports on Form 8-K

  

31

Signatures

  

32

Certificate of Chief Executive Officer

  

32

Certificate of Chief Financial Officer

  

33

 

2


Table of Contents

 

AMPEX CORPORATION

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

 

    

March 31, 2003


    

December 31, 2002


 

ASSETS

  

(unaudited)

        

Current assets:

                 

Cash and cash equivalents

  

$

5,475

 

  

$

7,579

 

Short-term investments

  

 

1,515

 

  

 

1,483

 

Accounts receivable (net of allowances of $196 in 2003 and $112 in 2002)

  

 

5,863

 

  

 

4,064

 

Inventories

  

 

7,029

 

  

 

7,336

 

Other current assets

  

 

3,035

 

  

 

2,368

 

    


  


Total current assets

  

 

22,917

 

  

 

22,830

 

Property, plant and equipment

  

 

5,498

 

  

 

5,757

 

Other assets

  

 

722

 

  

 

752

 

    


  


Total assets

  

$

29,137

 

  

$

29,339

 

    


  


LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT

                 

Current liabilities:

                 

Notes payable

  

$

304

 

  

$

457

 

Accounts payable

  

 

1,385

 

  

 

962

 

Net liabilities of discontinued operations

  

 

1,003

 

  

 

1,108

 

Accrued restructuring costs

  

 

1,300

 

  

 

1,300

 

Other accrued liabilities

  

 

10,205

 

  

 

10,471

 

    


  


Total current liabilities

  

 

14,197

 

  

 

14,298

 

Long-term debt

  

 

70,367

 

  

 

68,218

 

Other liabilities

  

 

64,515

 

  

 

64,413

 

Accrued restructuring costs

  

 

1,353

 

  

 

1,700

 

Net liabilities of discontinued operations

  

 

2,843

 

  

 

3,024

 

    


  


Total liabilities

  

 

153,275

 

  

 

151,653

 

    


  


Commitments and contingencies (Note 7)

                 

Mandatorily redeemable nonconvertible preferred stock, $1,000 liquidation value:
Authorized: 69,970 shares in 2003 and in 2002
Issued and outstanding—none in 2003 and in 2002

  

 

—  

 

  

 

—  

 

Mandatorily redeemable preferred stock, $2,000 liquidation value:
Authorized: 21,859 shares in 2003 and in 2002
Issued and outstanding—12,340 shares in 2003; 12,877 in 2002

  

 

24,680

 

  

 

25,754

 

Convertible preferred stock, $2,000 liquidation value:
Authorized: 10,000 shares in 2003 and in 2002
Issued and outstanding—none in 2003 and in 2002

  

 

—  

 

  

 

—  

 

Stockholders’ deficit:

                 

Preferred stock, $1.00 par value:
Authorized: 898,171 shares in 2003 and in 2002
Issued and outstanding—none in 2003 and in 2002

  

 

—  

 

  

 

—  

 

Common stock, $.01 par value:

                 

Class A:
Authorized: 175,000,000 shares in 2003 and in 2002
Issued and outstanding—63,841,796 shares in 2003; 63,412,196 shares in 2002

  

 

638

 

  

 

634

 

Class C:
Authorized: 50,000,000 shares in 2003 and in 2002
Issued and outstanding—none in 2003 and in 2002

  

 

—  

 

  

 

—  

 

Other additional capital

  

 

428,969

 

  

 

427,899

 

Accumulated deficit

  

 

(514,760

)

  

 

(512,828

)

Accumulated other comprehensive income

  

 

(63,665

)

  

 

(63,773

)

    


  


Total stockholders’ deficit

  

 

(148,818

)

  

 

(148,068

)

    


  


Total liabilities, redeemable preferred stock and stockholders’ deficit

  

$

29,137

 

  

$

29,339

 

    


  


 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

3


Table of Contents

 

AMPEX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(in thousands, except share and per share data)

 

    

For the Three Months Ended


 
    

March 31,

2003


    

March 31,

2002


 
    

(unaudited)

 

Royalty income

  

$

386

 

  

$

1,215

 

Product revenue

  

 

8,244

 

  

 

8,770

 

    


  


Total revenue

  

 

8,630

 

  

 

9,985

 

    


  


Intellectual property costs

  

 

245

 

  

 

232

 

Cost of product sales

  

 

4,216

 

  

 

5,220

 

Research, development and engineering

  

 

685

 

  

 

681

 

Selling and administrative

  

 

3,082

 

  

 

2,632

 

    


  


Total costs and operating expenses

  

 

8,228

 

  

 

8,765

 

    


  


Operating income

  

 

402

 

  

 

1,220

 

Interest expense

  

 

2,221

 

  

 

2,123

 

Amortization of debt financing costs

  

 

14

 

  

 

417

 

Interest income

  

 

(13

)

  

 

(162

)

Other (income) expense, net

  

 

10

 

  

 

(3

)

    


  


Loss before income taxes

  

 

(1,830

)

  

 

(1,155

)

Provision for income taxes

  

 

102

 

  

 

153

 

    


  


Net loss

  

 

(1,932

)

  

 

(1,308

)

Benefit from extinguishment of mandatorily redeemable preferred stock

  

 

1,036

 

  

 

1,104

 

    


  


Net loss applicable to common stockholders

  

 

(896

)

  

 

(204

)

Other comprehensive loss, net of tax:

                 

Foreign currency translation adjustments

  

 

10

 

  

 

(9

)

Minimum pension adjustment

  

 

(118

)

  

 

—  

 

    


  


Comprehensive loss

  

$

(1,004

)

  

$

(213

)

    


  


Basic and diluted loss per share :

                 

Loss per share

  

$

(0.03

)

  

$

(0.02

)

Loss per share applicable to common stockholders

  

$

(0.01

)

  

$

0.00

 

    


  


Weighted average number of common shares outstanding

  

 

63,416,917

 

  

 

61,658,165

 

    


  


 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

4


Table of Contents

 

AMPEX CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

    

For the Three Months Ended


 
    

March 31, 2003


    

March 31, 2002


 
    

(unaudited)

 

Cash flows from operating activities:

                 

Net loss

  

$

(1,932

)

  

$

(1,308

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

                 

Depreciation, amortization and warrant accretion

  

 

302

 

  

 

301

 

Accretion of interest expense

  

 

2,418

 

  

 

2,030

 

Periodic pension cost

  

 

118

 

  

 

—  

 

Net loss on disposal of assets

  

 

—